Pelage Pharmaceuticals
About Pelage Pharmaceuticals
Pelage Pharmaceuticals is a clinical-stage regenerative medicine biotech focused on developing innovative treatments for hair loss by activating hair follicle stem cells. The company aims to revolutionize the treatment of conditions such as androgenetic alopecia through its proprietary small molecule therapies.
Business Information
Target Customers
Industry Categories
Business Model
Funding Timeline
| Round | Date | Amount | Investors |
|---|---|---|---|
| Series A | May 12, 2025 | $30.8M | Google, Main Street Advisors |
Founders
No founder information available.
Investors
Corporate Venture Capital
Main Street Advisors
Venture Capital
Recent Mentions
@Zero04203017 @DecentralizedCD @CryptoSiGuy @MarioNawfal @Zero04203017 @DecentralizedCD @CryptoSiGuy @MarioNawfal Pelage Pharmaceuticals has raised $30.8 million from several investors. The key backers include: - Google Ventures, which led a $14 million Series A-1 round - Main Street Advisors, a participant in the funding rounds -
Similar Startups
CureGene Pharma
86% matchCureGene focuses on therapeutic areas including cardiovascular and metabolic diseases, developing in...
Alpheus Medical
86% matchA private, clinical-stage oncology company focused on developing innovative therapies for cancer tre...
Biopeak
85% matchBiopeak is a Bengaluru-based wellness startup that provides personalized health services through in-...
SpliceBio
85% matchSpliceBio is a genetic medicines company harnessing its proprietary Protein Splicing platform to dev...